Madrigal pharmaceuticals provides corporate updates and reports first quarter 2023 financial results

Conshohocken, pa., may 09, 2023 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq:mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (nash), today provides a summary of corporate updates and reports first quarter 2023 financial results.
MDGL Ratings Summary
MDGL Quant Ranking